RECRUITING

Imaging of Retinochoroidal Vasculature in Patients Being Assessed for Cardiovascular Disease

Talk to us

Conditions

Cardiovascular DiseasesRetina; Changeretinal vasculaturecardiovascular diseaseswept source optical coherence tomography angiographySS-OCTAcarotid duplex ultrasonography

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to determine whether changes in retinal vasculature seen on SS-OCTA can be correlated to degree of cardiovascular disease as measured by carotid duplex ultrasonography.

Official Title

Imaging of Retinochoroidal Vasculature in Patients Being Assessed for Cardiovascular Disease

Quick Facts

Study Start:2021-08-17
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05082402

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Subjects between 18 and 80 years of age.
  2. * No known prior history of retinal disease.
  3. * Able to participate in a clinical eye examination setting.
  4. * Able to consent.
  5. * Subjects receiving standard of care carotid duplex ultrasounds.
  1. * Known ophthalmologic disease (e.g. glaucoma, macular degeneration, ocular injury) other than corrected refractive error.
  2. * Lack of capacity to provide informed consent.
  3. * Subjects younger than 18 years of age or older than 80 years of age.
  4. * History of stroke or acute loss of vision.
  5. * Unable to participate in a clinical eye examination setting.

Contacts and Locations

Study Contact

Arnold Nadel
CONTACT
224-436-3677
arnold.nadel@northwestern.edu
Clinical Research Office
CONTACT
312-503-4849
ophthoresearch@northwestern.edu

Principal Investigator

Rukhsana Mirza, MD
PRINCIPAL_INVESTIGATOR
Northwestern University

Study Locations (Sites)

Northwestern University/Northwestern Medical Group, Department of Ophthalmology
Chicago, Illinois, 60611
United States

Collaborators and Investigators

Sponsor: Northwestern University

  • Rukhsana Mirza, MD, PRINCIPAL_INVESTIGATOR, Northwestern University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-08-17
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2021-08-17
Study Completion Date2024-12-31

Terms related to this study

Keywords Provided by Researchers

  • retinal vasculature
  • cardiovascular disease
  • swept source optical coherence tomography angiography
  • SS-OCTA
  • carotid duplex ultrasonography

Additional Relevant MeSH Terms

  • Cardiovascular Diseases
  • Retina; Change